4164 Chengye Medical: Announces Shareholder Dividend Distribution by Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
AI Summary (NQ-processed)
Chengye Medical announces that its key subsidiary, Fu Kang Active Pharmaceutical Co., Ltd., has resolved to distribute a cash dividend of TWD 77,475,270 following a shareholder meeting resolution, reflecting stable profitability and shareholder returns.
AI Analysis
Frequently Asked Questions
Q: What is Chengye Medical?
A: A Taiwan-based healthcare company operating through subsidiaries in pharmaceuticals and wellness.
Q: When will the dividend be paid?
A: The payment date has not been announced, but typically occurs within 1–2 months after resolution.
Q: What does Fu Kang Active Pharmaceutical do?
A: It focuses on pharmaceutical development and distribution in Taiwan’s domestic market.
Q: Does this announcement affect investment decisions?
A: Stable dividends signal financial health, making it a positive indicator for long-term investors.
Q: Where is Chengye Medical listed?
A: It is listed on the Taiwan Stock Exchange under ticker 4164.